Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel

Masatoshi Kubo; Masaru Jida; Masaomi Yamane; Katsuya Miyatani; Tetsunobu Udaka; Osanori Sogabe; Hiroya Maeda; Minoru Mizuta; Kazutoyo Shirakawa

Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel

Masatoshi Kubo, Masaru Jida, Masaomi Yamane, Katsuya Miyatani, Tetsunobu Udaka, Osanori Sogabe, Hiroya Maeda, Minoru Mizuta, Kazutoyo Shirakawa

Research output: Contribution to journal › Article › peer-review

Abstract

Carcinomatous meningitis from breast cancer is rare and has a poor prognosis with a life expectancy of approximately 80 days. We performed intrathecal MTX and Ara-C in combination with systemic docetaxel treatments in the patient, a 44-year-old woman with carcinomatous meningitis from invasive lobular carcinoma previously treated with anthracycline and paclitaxel. Although the patient died 128 days after the onset, intrathecal chemotherapy in combination with systemic docetaxel reduced the number of malignant cells and induced degeneration of the cells in CSF, resulting in improved quality of life.

Original language	English
Pages (from-to)	2097-2099
Number of pages	3
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	32
Issue number	13
Publication status	Published - Dec 2005
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel. / Kubo, Masatoshi; Jida, Masaru; Yamane, Masaomi et al.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 32, No. 13, 12.2005, p. 2097-2099.

Research output: Contribution to journal › Article › peer-review

@article{a5e8da69c99140f78b6d17b6481ecf02,

title = "Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel",

abstract = "Carcinomatous meningitis from breast cancer is rare and has a poor prognosis with a life expectancy of approximately 80 days. We performed intrathecal MTX and Ara-C in combination with systemic docetaxel treatments in the patient, a 44-year-old woman with carcinomatous meningitis from invasive lobular carcinoma previously treated with anthracycline and paclitaxel. Although the patient died 128 days after the onset, intrathecal chemotherapy in combination with systemic docetaxel reduced the number of malignant cells and induced degeneration of the cells in CSF, resulting in improved quality of life.",

author = "Masatoshi Kubo and Masaru Jida and Masaomi Yamane and Katsuya Miyatani and Tetsunobu Udaka and Osanori Sogabe and Hiroya Maeda and Minoru Mizuta and Kazutoyo Shirakawa",

year = "2005",

month = dec,

language = "English",

volume = "32",

pages = "2097--2099",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "13",

}

TY - JOUR

T1 - Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel

AU - Kubo, Masatoshi

AU - Jida, Masaru

AU - Yamane, Masaomi

AU - Miyatani, Katsuya

AU - Udaka, Tetsunobu

AU - Sogabe, Osanori

AU - Maeda, Hiroya

AU - Mizuta, Minoru

AU - Shirakawa, Kazutoyo

PY - 2005/12

Y1 - 2005/12

N2 - Carcinomatous meningitis from breast cancer is rare and has a poor prognosis with a life expectancy of approximately 80 days. We performed intrathecal MTX and Ara-C in combination with systemic docetaxel treatments in the patient, a 44-year-old woman with carcinomatous meningitis from invasive lobular carcinoma previously treated with anthracycline and paclitaxel. Although the patient died 128 days after the onset, intrathecal chemotherapy in combination with systemic docetaxel reduced the number of malignant cells and induced degeneration of the cells in CSF, resulting in improved quality of life.

AB - Carcinomatous meningitis from breast cancer is rare and has a poor prognosis with a life expectancy of approximately 80 days. We performed intrathecal MTX and Ara-C in combination with systemic docetaxel treatments in the patient, a 44-year-old woman with carcinomatous meningitis from invasive lobular carcinoma previously treated with anthracycline and paclitaxel. Although the patient died 128 days after the onset, intrathecal chemotherapy in combination with systemic docetaxel reduced the number of malignant cells and induced degeneration of the cells in CSF, resulting in improved quality of life.

UR - http://www.scopus.com/inward/record.url?scp=33644686180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644686180&partnerID=8YFLogxK

M3 - Article

C2 - 16352935

AN - SCOPUS:33644686180

VL - 32

SP - 2097

EP - 2099

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 13

ER -

Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this